Astria Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 24.1M | 25.9M | 27.8M | 20.2M | 20.5M | 20.7M | 15.7M | 26.9M |
| Operating Expenses | 34.8M | 35.8M | 37.0M | 29.6M | 29.0M | 28.8M | 24.1M | 34.2M |
| Operating Income | -34.1M | -35.8M | -37.0M | -29.6M | -29.0M | -28.8M | -24.1M | -34.2M |
| Other Income / Gains | 2.5M | 2.8M | 3.3M | 4.0M | 4.5M | 4.6M | 4.2M | 2.8M |
| Net Income | -31.6M | -33.1M | -33.7M | -25.6M | -24.5M | -24.2M | -19.9M | -31.4M |
| EPS (Diluted) | -0.55 | -0.57 | -0.58 | -0.45 | -0.43 | -0.43 | -0.38 | -0.86 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 10.7M | 9.9M | 9.2M | 9.3M | 8.5M | 8.1M | 8.4M | 7.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 400K | 0 | 0 | 0 | 100K |
| Selling General And Administrative Expenses | 10.7M | 9.9M | 9.2M | 9.7M | 8.5M | 8.1M | 8.4M | 7.4M |
| Other Expenses | 0 | 0 | 0 | -231K | 0 | 0 | 0 | -91K |
| Cost And Expenses | 34.8M | 35.8M | 37.0M | 29.6M | 29.0M | 28.8M | 24.1M | 34.2M |
| Interest Income | 2.5M | 2.9M | 3.3M | 4.0M | 4.5M | 4.6M | 4.2M | 2.8M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 43K | 0 |
| Ebitda | -31.6M | -33.1M | -33.7M | -25.6M | -24.5M | -24.2M | -19.9M | -19.0M |
| Ebitdaratio | -44.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | -48.306 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -31.6M | -33.1M | -33.7M | -25.6M | -24.5M | -24.2M | -19.9M | -31.4M |
| Income Before Tax Ratio | -44.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -44.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.55 | -0.57 | -0.58 | -0.45 | -0.43 | -0.43 | -0.38 | -0.86 |
| Weighted Average Shs Out | 58.0M | 58.0M | 58.0M | 56.4M | 56.5M | 56.5M | 52.3M | 36.5M |
| Weighted Average Shs Out Dil | 58.0M | 58.0M | 58.0M | 56.4M | 56.5M | 56.5M | 52.3M | 36.5M |